**Report on The National Institute of Pharmaceutical Education and Research Amendment Act, 2021**
**1. Executive Summary:**
This report analyzes the National Institute of Pharmaceutical Education and Research Amendment Act, 2021 based on the provided government policy text. This Act amends the National Institute of Pharmaceutical Education and Research Act, 1998. The core purpose of the amendment is to declare certain institutions of pharmaceutical education and research as institutions of national importance and to establish a central council to coordinate the activities of these institutes. Key changes include substituting the long title of the original act, modifying definitions, establishing a central council with specific functions, and altering the governance structure of the institutes. These changes aim to enhance the coordination and development of pharmaceutical education and research across the nation.
**2. Introduction:**
The purpose of this report is to provide an informative overview of The National Institute of Pharmaceutical Education and Research Amendment Act, 2021, based solely on the text provided. This report aims to clarify the changes introduced by the amendment and their potential implications for the pharmaceutical industry and related stakeholders.
**3. Policy Overview:**
* This Act amends the National Institute of Pharmaceutical Education and Research Act, 1998.
* **Core Objective(s):** Based on the provided text, the core objectives of this amendment are:
* To declare certain institutions of pharmaceutical education and research as institutions of national importance.
* To establish a central council (the "Council") to coordinate the activities of these institutions.
* To enhance the governance and functioning of these institutes to promote pharmaceutical education and research.
**4. Background and Rationale:**
The amendment addresses the need for a more coordinated and standardized approach to pharmaceutical education and research across various institutes in India. The establishment of the Council suggests a desire to improve the quality, relevance, and impact of pharmaceutical education and research by creating a central body to oversee and guide the activities of the National Institutes of Pharmaceutical Education and Research (NIPERs). Declaring certain institutes as institutions of national importance likely aims to provide them with greater recognition, resources, and autonomy.
**5. Key Provisions / Changes:**
The National Institute of Pharmaceutical Education and Research Amendment Act, 2021 introduces several key changes to the original Act of 1998:
* **Amendment of Long Title (Section 2):** The long title of the original act is substituted with: "An Act to declare certain institutions of pharmaceutical education and research to be institutions of national importance and for matters connected therewith or incidental thereto." This change reflects a broadened scope and intent, emphasizing the national importance designation.
* **Amendment of Section 1 (Section 3):** The word "Institute" is substituted with "Institutes".
* **Substitution of Section 2 (Section 4):** A new section 2 is substituted, explicitly declaring that the institutions mentioned in the Schedule are institutions of national importance and that every institute established after the commencement of this amendment act shall be considered as institution of national importance.
* **Amendment of Section 3 (Section 5):** This section modifies definitions. Notably, it adds definitions for "Council", "member", "prescribed", and "Schedule". It also modifies the definition of "Institute" to mean any of the institutions mentioned in the Schedule.
* **Amendment of Section 4 (Section 6):** This section changes the heading from "Establishment of Institute" to "Establishment and incorporation of Institutes". Subsection 1 is replaced, stating that "Each of the Institutes mentioned in column 3 of the Schedule shall be a body corporate." Subsection 3 is replaced, providing details about the Board of Governors of each Institute, specifying members such as a Chairperson nominated by the Visitor, the Director of the Institute, and representatives from the Government of India, State Governments, and pharmaceutical experts.
* **Omission of Section 5 (Section 8):** Section 5 of the principal act is omitted.
* **Insertion of Chapter IIA (Section 29):** This is a significant change, introducing a new chapter focusing on the establishment, composition, functions, and powers of the Council.
* **Establishment of Council (Section 30A):** This section establishes a central body called the Council to coordinate activities of all institutes specified in the Schedule. It defines the composition of the Council, including representatives from various government ministries, educational bodies, and industry associations.
* **Term of Office of Members (Section 30B):** Specifies the term of office for members of the Council, addressing vacancies and allowances.
* **Functions of Council (Section 30C):** The Council has the general duty to coordinate the activities of all the Institutes and to take all such steps as to ensure planned and coordinated development of pharmaceutical education and research and maintenance of standards thereof. Lists specific functions such as advising on academic matters, laying down policy, examining development plans, and promoting research and development.
* **Chairman of Council (Section 30D):** Details the role and responsibilities of the Chairperson of the Council.
* **Power to Make Rules (Section 30E):** Empowers the Central Government to make rules to carry out the provisions of Chapter IIA.
* **Amendment of Section 16 (Section 18):** This section replaces the words "Director of the Institute shall be appointed by the Board" with "Director of each Institute shall be appointed by the Council". This changes the appointment authority for the Director from the Board to the Council.
* **The Schedule (Section 35):** The Schedule lists the location, name, and date of establishment of the incorporated institutions.
**6. Target Audience and Stakeholders:**
Based on the provided text, the primary target audience and stakeholders include:
* The National Institutes of Pharmaceutical Education and Research (NIPERs) listed in the Schedule.
* The faculty, researchers, and students associated with these institutes.
* The Ministry of Law and Justice.
* The Department of Pharmaceuticals.
* The Central Government.
* The Council of Scientific and Industrial Research.
* The All India Council for Technical Education
* The pharmaceutical industry (including industrialists and experts).
* Related government bodies and regulatory agencies (e.g., Drug Controller General of India, Pharmacy Council of India).
**7. Implementation Aspects (Inferred):**
* **Responsible Agency/Bodies:** The Central Government, particularly the Ministry or Department dealing with Pharmaceuticals, is primarily responsible for implementing the amendments. The newly established Council will play a crucial role in coordinating and overseeing the activities of the NIPERs. The Board of Governors of each institute will also be involved in implementing the changes at the individual institute level.
* **Timelines/Procedures:** The Act comes into force on a date to be appointed by the Central Government via notification in the Official Gazette. The establishment of the Council will also be effective from a date specified by the Central Government through notification. The text outlines procedures for nominating or electing members of the Council and for the Council's meetings. The Central Government is empowered to make rules for carrying out the provisions of Chapter IIA.
**8. Expected Outcomes / Impact of Changes:**
The expected outcomes of these specific changes include:
* **Enhanced Coordination:** The establishment of the Council should lead to better coordination among the NIPERs, facilitating the sharing of resources, best practices, and expertise.
* **Improved Standards:** The Council's role in setting policies and guidelines is expected to improve the quality and standards of pharmaceutical education and research across the NIPERs.
* **Greater Industry Collaboration:** The inclusion of industry representatives in the Council is intended to foster closer collaboration between academia and industry, ensuring that the research and training provided by the NIPERs are relevant to the needs of the pharmaceutical sector.
* **Streamlined Governance:** The changes to the composition of the Board of Governors and the appointment process for Directors aim to streamline the governance of the NIPERs and enhance their autonomy.
* **National Importance Recognition:** Designating the NIPERs as institutions of national importance should attract more funding, talent, and recognition, further strengthening their position as leading centers for pharmaceutical education and research.
**9. Conclusion:**
The National Institute of Pharmaceutical Education and Research Amendment Act, 2021 represents a significant step towards enhancing the pharmaceutical education and research landscape in India. By declaring certain institutes as institutions of national importance and establishing a central coordinating council, the amendment aims to promote excellence, collaboration, and innovation in the pharmaceutical sector. These changes are expected to have a positive impact on the quality of pharmaceutical education, the relevance of research, and the overall competitiveness of the Indian pharmaceutical industry.
Key Entities Referenced
Parliament: Legislative body that enacted the National Institute of Pharmaceutical Education and Research Amendment Act, 2021
President: The President of India, who gave assent to the National Institute of Pharmaceutical Education and Research Amendment Act, 2021
National Institute of Pharmaceutical Education and Research Amendment Act, 2021: Act of Parliament further amending the National Institute of Pharmaceutical Education and Research Act, 1998
National Institute of Pharmaceutical Education and Research Act, 1998: The principal Act that is being amended by the National Institute of Pharmaceutical Education and Research Amendment Act, 2021.
Central Government: The government responsible for appointing the date of enforcement of the Act and establishing the Council.
Official Gazette: The official publication where the Central Government will announce the date of enforcement of the Act and establishment of the Council
Council: A central body established to coordinate the activities of all the Institutes, as defined under Chapter IIA of the Act.
All India Council for Technical Education: An ex-officio member of the Council.
Council of Scientific and Industrial Research: An ex-officio member of the Council.
House of the People: The lower house of the Parliament, from which two members are elected to the Council.
Council of States: The upper house of the Parliament, from which one member is elected to the Council.
Indian Drugs Manufacturing Association: An ex-officio member of the Council.
Organisation of Pharmaceutical Producers of India: An ex-officio member of the Council.
Pharmacy Council of India: An ex-officio member of the Council.
National Institute of Pharmaceutical Education and Research, Mohali, Punjab: One of the National Institutes of Pharmaceutical Education and Research, specifically mentioned in relation to existing Statutes and Ordinances.
Ahmedabad, Gujarat: Location of one of the National Institute of Pharmaceutical Education and Research.
Hajipur, Bihar: Location of one of the National Institute of Pharmaceutical Education and Research.
Hyderabad, Telengana: Location of one of the National Institute of Pharmaceutical Education and Research.
Kolkata, West Bengal: Location of one of the National Institute of Pharmaceutical Education and Research.
Guwahati, Assam: Location of one of the National Institute of Pharmaceutical Education and Research.
Raebareli, Uttar Pradesh: Location of one of the National Institute of Pharmaceutical Education and Research.
Department of Pharmaceuticals: The department within the Government of India dealing with the national institutes of pharmaceutical education and research.
Ministry of Health and Family Welfare: The ministry which Drug Controller General of India belongs to.
jftLVªh lañ Mhñ ,yñ—(,u)04@0007@2003—21
REGISTERED NO. DL—(N)04/0007/2003—21
xxxGIDHxxx
सी.जी.-डी.एल.-अ.-21122021-232027
CG-DxLx-xEG-2I1D12E20x2x1x-232027
vlk/kkj.k
EXTRAORDINARY
Hkkx [k.M
II — 1
PART II—Section 1
izkf/kdkj ls izdkf'kr
PUBLISHED BY AUTHORITY
lañ 60 ubZ fnYyh] lkseokj] fnlEcj 20] 2021@vxzgk;.k 29] 1943 ¼'kd½
]
No. 60] NEW DELHI, MONDAY, DECEMBER 20, 2021/AGRAHAYANA 29, 1943 (SAKA)
bl Hkkx esa fHkUu i`"B la[;k nh tkrh gS ftlls fd ;g vyx ladyu ds :i esa j[kk tk ldsA
Separate paging is given to this Part in order that it may be filed as a separate compilation.
MINISTRY OF LAW AND JUSTICE
(Legislative Department)
New Delhi, the 20th December, 2021/ Agrahayana 29, 1943 (Saka)
The following Act of Parliament received the assent of the President on the
18th December, 2021 and is hereby published for general information:—
THE NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION
AND RESEARCH (AMENDMENT) ACT, 2021
(NO. 43 OF 2021)
[18th December, 2021]
An Act further to amend the National Institute of Pharmaceutical Education and Research
Act, 1998.
BE it enacted by Parliament in the Seventy-second year of the Republic of India as
follows:—
CHAPTER I
PRELIMINARY
1. (1) This Act may be called the National Institute of Pharmaceutical Education and Short title and
Research (Amendment) Act, 2021. commencement.
(2) It shall come into force on such date as the Central Government may, by notification
in the Official Gazette, appoint.2 THE GAZETTE OF INDIA EXTRAORDINARY [PART II—
Amendment 2. In the National Institute of Pharmaceutical Education and Research Act, 1998 13 of 1998.
of long title. (hereinafter referred to as the principal Act), for the long title, the following long title shall be
substituted, namely:—
“An Act to declare certain institutions of pharmaceutical education and research
to be institutions of national importance and for matters connected therewith or
incidental thereto.”.
Amendment 3. In section 1 of the principal Act, in sub-section (1), for the word “Institute”, the word
of section 1. “Institutes” shall be substituted.
Substitution of 4. For section 2 of the principal Act, the following section shall be substituted, namely:—
new section for
section 2.
Declaration of “2. (1) Whereas the objects of the institutions mentioned in the Schedule, are
certain such as to make them institutions of national importance, it is hereby declared that
institutions as
each such Institute is an institution of national importance.
institutions of
national (2) It is hereby declared that every Institute established under sub-section (2A)
importance.
of section 4, on and after the commencement of the National Institute of Pharmaceutical
Education and Research (Amendment) Act, 2021, shall be an institution of national
importance.”.
Amendment 5. In section 3 of the principal Act,––
of section 3.
(i) for clause (a), the following clause shall be substituted, namely:––
‘(a) “appointed day”, in relation to an Institute mentioned in column (3) of
the Schedule, means the date of its establishment as mentioned against it in
column (4) of that Schedule;’;
(ii) in clauses (b) and (c), for the words “the Institute”, the words “an Institute”
shall be substituted;
(iii) after clause (c), the following clause shall be inserted, namely:––
‘(ca) “Council” means the Council established under sub-section (1) of
section 30A;’;
(iv) in clauses (d), (e) and (f), for the words “the Institute”, the words “an Institute”
shall be substituted;
(v) for clause (g), the following clauses shall be substituted, namely:—
‘(g) “Institute” means any of the institutions mentioned in column (3) of
the Schedule;
(ga) “member” means a member of the Council nominated or elected under
sub-section (2) of section 30A;
(gb) “prescribed” means prescribed by rules made under this Act;
(gc) “Schedule” means the Schedule to this Act;’;
(vi) in clauses (h) and (j), for the words “the Institute”, the words “an Institute”
shall be substituted.
Amendment 6. In section 4 of the principal Act,––
of section 4.
(i) in the marginal heading, for the words “Establishment of Institute”, the words
“Establishment and incorporation of Institutes” shall be substituted;
(ii) for sub-section (1), the following sub-section shall be substituted, namely:—
“(1) Each of the Institutes mentioned in column (3) of the Schedule shall
be a body corporate.”;SEC. 1] THE GAZETTE OF INDIA EXTRAORDINARY 3
(iii) in sub-section (2), for the words “The Institute”, the words “Each Institute”
shall be substituted;
(iv) for sub-section (3), the following sub-section shall be substituted, namely:—
“(3) The Board of Governors of an Institute shall consist of the following
persons, namely:—
(a) a Chairperson, who shall be an eminent academician or scientist
or technologist or professional, to be nominated by the Visitor;
(b) the Director of the institute, ex officio;
(c) the Joint Secretary to the Government of India in Department of
Pharmaceuticals dealing with the national institutes of pharmaceutical
education and research, ex officio;
(d) the Secretary, dealing with medical or technical education in the
State Government concerned, ex officio;
(e) the representative of Drug Controller General of India, Ministry
of Health and Family Welfare of the Government of India, ex officio;
(f) three eminent pharmaceutical experts, at least one of whom shall
be a woman, having special knowledge or practical experience in education,
research and biotechnology, to be nominated by the Council;
(g) two pharmaceutical industrialists to be nominated by the Council;
(h) two professors of the institute, to be nominated by the Senate:
Provided that one member from amongst members to be nominated
under clauses (f), (g) and (h) shall be either from the Scheduled Castes or
from the Scheduled Tribes;”;
(v) in sub-section (4), the proviso shall be omitted.
7. In section 4A of the principal Act, the words “within its jurisdiction” shall be omitted. Amendment of
section 4A.
8. Section 5 of the principal Act shall be omitted. Omission of
section 5.
9. In section 6 of the principal Act,–– Amendment
of section 6.
(i) for the words “On and from the appointed day”, the words “On and from the
appointed day, in relation to the National Institute of Pharmaceutical Education and
Research, Mohali” shall be substituted;
(ii) after clause (a), the following clause shall be inserted, namely:––
“(aa) all property, movable and immovable of, or belonging to, the Society,
shall vest in that Institute;”;
(iii) for the words “the Institute”, wherever they occur, the words “that Institute”
shall be substituted.
10. In section 7 of the principal Act,––
Amendment
of section 7.
(a) in the marginal heading, for the word “Institute”, the word “Institutes” shall
be substituted;
(b) for clause (ii), the following clauses shall be substituted, namely:––
“(ii) to develop courses leading to graduate and post graduate degrees,
doctoral and post-doctoral distinctions and research in pharmaceutical education
or to develop integrated courses relating thereto;
(iia) to conduct executive education courses, short-term certificate courses,
training programmes, online or distant education, diploma courses and such
other short-term executive courses;”;4 THE GAZETTE OF INDIA EXTRAORDINARY [PART II—
(c) in clause (v), for the words “ by exchange of faculty members”, the words “by
promoting collaborative research, exchange of faculty members, researchers” shall be
substituted;
(d) after clause (x), the following clause shall be inserted, namely:––
“(xa) to establish Centres of Excellence for drug discovery and development
and medical devices;”.
Amendment 11. In section 8 of the principal Act, for the word “Board”, wherever it occurs, the
of section 8. words “Board of an Institute” shall be substituted.
Amendment 12. In section 9 of the principal Act,––
of section 9.
(i) in the marginal heading, for the word “Institute”, the word “Institutes” shall
be substituted;
(ii) in sub-section (1), for the words “The Institute”, the words “Every Institute”
shall be substituted;
(iii) in sub-section (2), for the words “the Institute”, the words “any Institute”
shall be substituted.
Amendment 13. In section 10 of the principal Act,––
of section 10.
(i) in the marginal heading, for the word “Institute”, the word “Institutes” shall
be substituted;
(ii) for the words “the Institute”, the words “each of the Institutes” shall be
substituted.
Amendment 14. In section 11 of the principal Act,––
of section 11.
(i) in sub-section (1), for the words “the Institute”, the words “every Institute”
shall be substituted;
(ii) in sub-section (2), for the words “the Institute”, the words “any Institute”
shall be substituted.
Amendment 15. In section 12 of the principal Act,––
of section 12.
(i) in the marginal heading, for the word “Institute”, the word “Institutes” shall
be substituted;
(ii) in the opening portion, for the words “the Institute”, the words “an Institute”
shall be substituted.
Amendment 16. In section 13 of the principal Act, in the opening portion, for the words “the
of section 13. Institute”, the words “each Institute” shall be substituted.
Amendment 17. In section 14 of the principal Act, for the words “senate of the Institute”, the words
of section 14. “senate of each Institute” shall be substituted.
Amendment 18. In section 16 of the principal Act, in sub-section (1), for the words "Director of the
of section 16. Institute shall be appointed by the Board" the words "Director of each Institute shall be
appointed by the Council" shall be substituted.
Amendment 19. In section 17 of the principal Act, for the words “the Institute”, the words “each
of section 17. Institute” shall be substituted.
Amendment 20. In section 18 of the principal Act, for the words “Registrar of the Institute”, the
of section 18. words “Registrar of each Institute” shall be substituted.
Amendment 21. In section 20 of the principal Act,––
of section 20.
(i) for the words “enabling the Institute”, the words “enabling the Institutes”
shall be substituted;SEC. 1] THE GAZETTE OF INDIA EXTRAORDINARY 5
(ii) for the words “pay to the Institute”, the words “pay to each Institute” shall
be substituted.
22. In section 21 of the principal Act,–– Amendment
of section 21.
(i) in the marginal heading, for the word “Institute”, the word “Institutes” shall
be substituted;
(ii) in sub-section (1), for the words “The Institute shall”, the words “Every
Institute shall” shall be substituted.
23. In section 22 of the principal Act, for the words “the Institute”, the words “every Amendment
Institute” shall be substituted. of section 22.
24. In section 23 of the principal Act,–– Amendment
of section 23.
(i) in sub-section (1), for the words “The Institute”, the words “Every Institute”
shall be substituted;
(ii) in sub-section (2), for the words “the Institute”, the words “every Institute”
shall be substituted;
(iii) in sub-section (3), for the words “accounts of the Institute”, the words
“accounts of any Institute” shall be substituted;
(iv) in sub-section (4), for the words “the Institute”, the words “every Institute”
shall be substituted.
25. In section 24 of the principal Act, in sub-section (1), for the words “The Institute”, Amendment
the words “Every Institute” shall be substituted. of section 24.
26. In section 25 of the principal Act, for the words “the Institute”, the words “an Amendment
Institute” shall be substituted. of section 25.
27. In section 27 of the principal Act, in sub-section (1), for the words “the Institute”, Amendment
the words “every Institute” shall be substituted. of section 27.
28. In section 28 of the principal Act, for the words “Ordinances of the Institute”, the Amendment
words “Ordinances of each Institute” shall be substituted. of section 28.
29. After Chapter II of the principal Act, the following Chapter shall be inserted, Insertion of
namely:–– new Chapter
II-A.
“CHAPTER II-A
THE COUNCIL
30A. (1) With effect from such date as the Central Government may, by notification Establishment
in the Official Gazette, specify in this behalf, there shall be established for all the of Council.
Institutes specified in column (3) of the Schedule, a central body to be called the
Council.
(2) The Council shall consist of the following members, namely:––
(a) Minister in charge of the Ministry or Department of the Central
Government having administrative control of the Pharmaceuticals, ex officio, as
Chairperson;
(b) Minister of State in the Ministry or Department of the Central
Government having administrative control of the Pharmaceuticals, ex officio, as
Vice-Chairperson;
(c) the Secretary to the Government of India in charge of the Ministry or
Department of the Central Government having administrative control of the
Pharmaceuticals, ex officio;6 THE GAZETTE OF INDIA EXTRAORDINARY [PART II—
(d) the Chairperson of every Board of Governors, ex officio;
(e) the Director of every Institute, ex officio;
(f) the Chairperson, All India Council for Technical Education, ex officio;
(g) the Director General, Council of Scientific and Industrial Research,
ex officio;
(h) four Secretaries to the Government of India, to represent the Ministries
or Departments of the Central Government dealing with Biotechnology, Health
Research, Higher Education and Science and Technology, ex officio;
(i) not less than three, but not more than five persons to be nominated by
the Visitor, at least one of whom shall be a woman, having special knowledge or
practical experience in education, pharmaceutical industry, medical devices
industry or pharmaceutical research;
(j) three members of Parliament of whom two shall be elected by the House
of the People and one by the Council of States, from amongst its members;
(k) the President, Indian Drugs Manufacturing Association, ex officio;
(l) the President, Organisation of Pharmaceutical Producers of India,
ex officio;
(m) the President, Pharmacy Council of India, ex officio;
(n) the Financial Advisor of the Ministry or Department of the Central
Government dealing with Pharmaceuticals, ex officio;
(o) the Joint Secretary to the Government of India in the Ministry or
Department of the Central Government having administrative control of the
Pharmaceuticals, ex officio, as Member-Secretary.
(3) It is hereby declared that the office of a member of the Council shall not
disqualify its holder for being chosen as, or for being, a member of either House of
Parliament.
Term of office 30B. (1) Save as otherwise provided in this section, the term of office of a
of, vacancies member of the Council shall be three years from the date of his nomination or election,
among, and
as the case may be.
allowances
payable to, (2) The term of office of an ex officio member shall continue so long as he holds
members of
the office by virtue of which he is a member.
Council.
(3) The term of office of a member elected under clause (j) of sub-section (2) of
section 30A shall come to an end as soon as he becomes a Minister or Minister of State
or Deputy Minister, or the Speaker or the Deputy Speaker of the House of the People,
or the Deputy Chairperson of the Council of States or ceases to be a member of the
House which elected him.
(4) The term of office of a member nominated or elected to fill a casual vacancy
shall continue for the remainder of the term of the member in whose place he has been
nominated or elected.
(5) Notwithstanding anything contained in this section an outgoing member
shall, unless the Central Government otherwise directs, continue in office until another
person is nominated or elected as a member in his place.
(6) The members of the Council shall be paid such travelling and other allowances
by the Central Government as may be determined by that Government, but no member
shall be entitled to any salary by reason of this sub-section.SEC. 1] THE GAZETTE OF INDIA EXTRAORDINARY 7
30C. (1) It shall be the general duty of the Council to coordinate the activities of Functions of
all the Institutes and to take all such steps as to ensure planned and coordinated Council.
development of pharmaceutical education and research and maintenance of standards
thereof.
(2) Without prejudice to the provisions of sub-section (1), the Council shall
perform the following functions, namely:—
(a) to advise on matters relating to the duration of the courses, the degrees
and other academic distinctions to be conferred by the Institutes, admission
standards and other academic matters;
(b) to lay down policy regarding cadres, methods of recruitment and
conditions of service of employees, institution of scholarships and free-ships,
levying of fees and other matters of common interest;
(c) to examine the development plans of each Institute and to approve
such of them as are considered necessary and also to indicate broadly the
financial implications of such approved plans;
(d) to lay down policy or guidelines for promoting research and
development in pharmaceuticals and related areas, fostering collaboration and
overseeing developments and on matters incidental thereto;
(e) to examine the annual budget estimates of each Institute and to
recommend to the Central Government the allocation of funds for that purpose;
(f) to advise the Visitor, if so required, in respect of any function to be
performed by him under this Act; and
(g) to perform such other functions as are assigned to it by or under this
Act.
(3) The Council shall meet at least once every six months and follow such
procedure in its meetings as may be prescribed.
30D. (1) The Chairperson of the Council shall ordinarily preside at the meetings Chairman of
of the Council: Council.
Provided that in the absence of the Chairperson, the Vice-Chairperson shall
preside at the meetings of the Council:
Provided further that in the absence of both the Chairperson and the
Vice-Chairperson, any other member, chosen from amongst themselves by the members
present at the meeting shall preside at that meeting.
(2) It shall be the duty of the Chairperson of the Council to ensure that the
decisions taken by the Council are implemented.
(3) The Chairman shall exercise such other powers and perform such other
duties as are assigned to him by this Act.
30E. (1) The Central Government may, by notification in the Official Gazette, Power to
make rules to carry out the provisions of this Chapter. make rules in
respect of
(2) In particular and without prejudice to the generality of the foregoing power, matters in this
such rules may provide for all or any of the following matters, namely:— Chapter.
(a) the manner of filling vacancies among the members of the Council;
(b) the disqualifications for being chosen as, and for being, a member of
the Council;
(c) the circumstances in which, and the authority by which, members may
be removed;8 THE GAZETTE OF INDIA EXTRAORDINARY [PART II—
(d) the meetings of the Council and the procedure of conducting business
thereat;
(e) the travelling and other allowances payable to members of the
Council; and
(f) the functions of the Council and the manner in which such functions
may be exercised.
(3) Every rule made by the Central Government under this Chapter shall be laid,
as soon as may be after it is made, before each House of Parliament, while it is in
session, for a total period of thirty days which may be comprised in one session or in
two or more successive sessions, and if, before the expiry of the session immediately
following the session or the successive sessions aforesaid, both Houses agree in
making any modification in the rule or both Houses agree that the rule should not be
made, the rule shall thereafter have effect only in such modified form or be of no effect,
as the case may be; so, however, that any such modification or annulment shall be
without prejudice to the validity of anything previously done under that rule.”.
Amendment of 30. In section 31 of the principal Act, for the words “No act of the Institute”, the words
section 31. “No act of the Council or any Institute” shall be substituted.
Amendment of 31. In section 32 of the principal Act,––
section 32.
(i) in the marginal heading, for the word “Institute”, the word “Institutes” shall
be substituted;
(ii) for the words “the Institute”, the words “every Institute” shall be substituted.
Amendment of 32. In section 33 of the principal Act, for the words “Whenever the Institute”, the
section 33. words “Whenever an Institute” shall be substituted.
Insertion of new 33. After section 33 of the principal Act, the following section shall be inserted,
section 33A. namely:––
Power of “33A. The Institute shall carry out such directions as may be issued to it from
Central time to time by the Central Government for the efficient administration of this Act.”.
Government
to issue
directions.
Amendment 34. In section 35 of the principal Act, for clause (b), the following clause shall be
of section 35. substituted, namely:––
“(b) until the first Statutes and the Ordinances in relation to the Institutes
mentioned in column (3) of the Schedule are made under this Act, the Statutes and the
Ordinances of the National Institute of Pharmaceutical Education and Research,
Sector-67, S.A.S. Nagar (Mohali), District Ropar, Punjab as in force, shall apply to
those Institutes with the necessary modifications and adaptations in so far as they are
not inconsistent with the provisions of this Act.”.SEC. 1] THE GAZETTE OF INDIA EXTRAORDINARY 9
THE SCHEDULE
[See sections 2(1), 3(a), (g), (gc), 4(1), 30A(1) and 35(b)]
Sl. Location of Name of institutions incorporated under Date of
No. this Act institute and the State establishment of
Institute
(1) (2) (3) (4)
1. Mohali, Punjab The National Institute of Pharmaceutical 8th July, 1998
Education and Research Society, Mohali
2. Ahmedabad, Gujarat The National Institute of Pharmaceutical 6th September, 2007
Education and Research, Ahmedabad
3. Hajipur, Bihar The National Institute of Pharmaceutical 6th September, 2007
Education and Research, Hajipur
4. Hyderabad, Telengana The National Institute of Pharmaceutical 6th September, 2007
Education and Research, Hyderabad
5. Kolkata, West Bengal The National Institute of Pharmaceutical 6th September, 2007
Education and Research, Kolkata
6. Guwahati, Assam The National Institute of Pharmaceutical 5th August, 2008
Education and Research, Guwahati
7. Raebareli, Uttar Pradesh The National Institute of Pharmaceutical 26th September, 2008
Education and Research, Raebareli
————
DR. REETA VASISHTA,
Secretary to the Govt. of India.
UPLOADED BY THE MANAGER, GOVERNMENT OF INDIA PRESS, MINTO ROAD, NEW DELHI–110002
AND PUBLISHED BY THE CONTROLLER OF PUBLICATIONS, DELHI–110054.
MGIPMRND—1655GI(S3)—20-12-2021.